1 Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! Mar 10, 2025
Read More Apparatus Clinical Approval For Colombotide Skb264 (Mk-2870) In Combination With Oxitinib Apr 05, 2025